12th Market Access, Pricing & Reimbursement Global Congress 2025 Europe

Nazanin approaches her work with one priority: getting access to life-changing therapies for people who need them. That focus has driven her thirty years in healthcare, from public sector to academic with twenty-four years of them in the pharmaceutical industry. Nazanin began her career as a pharmacist in the Canadian public healthcare system, with teaching engagements in cytogenetics. She saw an opportunity to help more people in an industry role and has served across multiple Market Access leadership roles coupled with regional practical experience in the US, Canada, Europe, and globally at two of the largest global pharma companies, Eli Lilly and Sanofi. Since joining Sanofi in 2003, Nazanin has held several Health Economics, market access and pricing leadership roles with accountability for multi-billion-dollar portfolios in multiple therapeutic areas, regenerative medicine plus medical devices. Nazanin is Always striving to achieve strategic business goals and securing local Access for patients while creating and operationalizing high-performing market access team functions (Pricing, HTA, HE, RWE). Nazanin possess a strong understanding of commercial operations with her experience in setting up the transformation of the Sanofi Diabetes Business model to address customer care pain points across multiple countries. Today, Nazanin leads Global Market Access and Pricing for Immunology at Sanofi. Nazanin and her team develop and implement the full immunology portfolio market access and pricing strategies. As a leader, Nazanin guides her teams to integrate medical, marketing and affiliates to demonstrate to payers the value of health care interventions across the health care delivery continuum.